New players to step into the AMR field
Despite challenging markets new players are entering the field to advance drug development in the fight against antimicrobial resistance.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2154 entries already.
Entries by Thomas Gabrielczyk
Test detects breast cancer in earliest stage
Sustainable DNA extraction
BioEcho develops single-spin and 96-well kits for the isolation of DNA from different starting materials. In contrast to common bind-wash-elute procedures their proprietary EchoLUTION single-step technology avoids the use of inhibitory or harmful process reagents and does not require washing steps.
Sherlock Bioscience and Mologic enter partnership
Synbio specialist Sherlock Biosciences and next-generation lateral flow testing expert Mologic Ltd have joined forces to develop a no-instrument rapid testing platform detecting virtually every infectious pathogen in low resource settings.
Protein protects against liver fibrosis
German researchers have shown that a protein protects against the development of liver fibrosis by shutting down inflammatory signalling in liver stellate cells of the liver.
bit bio restarts with new management
Cell reprogramming specialist bit bio has expanded its management with renowned experts in the field.
BioVersys receives up to €8m from CARB-X
Swiss biotech company BioVersys AG has received a €8m grant by US-based non-profit organisation CARB-X to develop novel anti-virulence antibiotics to treat severe bacterial infections.
Researchers identify viral inflammation switch
A team of Japanese and German researchers has found the protein that helps activate the inflammasome following viral invasion.
Rotavirus vaccines kill cancer cells
Researchers at University Lyon have found a potential repurposing application of two market-approved rotavirus vaccines.
Polyphor presents AMR breaker
Swiss Polyphor AG and researchers from the University of Zurich have presented the mechanism of action of a new class of antibiotics.